Literature DB >> 6744514

A simplified assay for O6-methylguanine-DNA methyltransferase activity and its application to human neoplastic and non-neoplastic tissues.

B Myrnes, K Norstrand, K E Giercksky, C Sjunneskog, H Krokan.   

Abstract

A rapid assay of O6-MeG-DNA methyltransferase activity is described. Following incubation of cell extracts with O6-[3H]MeG-containing DNA, remaining radioactive DNA was hydrolyzed in trichloroacetic acid and separated from methylated radioactive protein by filtration or centrifugation. Transfer of radioactive methyl from DNA to protein was proportional to the amount of protein added, and was not linear with time. More than 90% of the radioactivity precipitated after acid hydrolyses was in S-methyl cysteine residues. The method was used to measure O6-MeG-DNA methyltransferase activity in extracts of 24 neoplastic tissues from human organs. Although five tumor tissues had 28-84% lower activity of O6-MeG-DNA methyltransferase than the corresponding normal tissue from the same patient, higher or similar levels of activity were found more frequently. Thus, a lack of O6-MeG-DNA methyltransferase activity in human tumours appears not to be a frequent event. The DNA repair enzyme uracil-DNA glycosylase was also measured in the same extracts. Most frequently the level of uracil-DNA glycosylase activity was essentially similar in tumors and normal tissues but significantly higher or lower levels were also observed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744514     DOI: 10.1093/carcin/5.8.1061

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

1.  Direct assay for O6-methylguanine-DNA methyltransferase and comparison of detection methods for the methylated enzyme in polyacrylamide gels and electroblots.

Authors:  G N Major; E J Gardner; P D Lawley
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  Sensitization of human colon tumour cell lines to carmustine by depletion of O6-alkylguanine-DNA alkyltransferase.

Authors:  A Magull-Seltenreich; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Inhibition of O6-alkylguanine-DNA alkyltransferase in animal and human ovarian tumor cell lines by O6-benzylguanine and sensitization to BCNU.

Authors:  A Magull-Seltenreich; W J Zeller
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Requirement of the Pro-Cys-His-Arg sequence for O6-methylguanine-DNA methyltransferase activity revealed by saturation mutagenesis with negative and positive screening.

Authors:  K Ihara; H Kawate; L L Chueh; H Hayakawa; M Sekiguchi
Journal:  Mol Gen Genet       Date:  1994-05-25

5.  Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene.

Authors:  L C Harris; P M Potter; K Tano; S Shiota; S Mitra; T P Brent
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

6.  Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.

Authors:  Ameya Paranjpe; Ruiwen Zhang; Francis Ali-Osman; George C Bobustuc; Kalkunte S Srivenugopal
Journal:  Carcinogenesis       Date:  2013-11-05       Impact factor: 4.944

7.  O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents.

Authors:  R Bianchi; L Citti; R Beghetti; L Romani; M D'Incalci; P Puccetti; M C Fioretti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.

Authors:  T Hotta; Y Saito; T Mikami; K Kurisu; K Kiya; T Uozumi; G Isowa; K Ishizaki; M Ikenaga
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

10.  Enhancement of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) toxicity by acetohydroxamic acid analogues of 3-nitropyrazole in vitro.

Authors:  R T Mulcahy; D J Wustrow; R R Hark; A S Kende
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.